{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:20:44Z","timestamp":1790032844524,"version":"4.0.1"},"reference-count":12,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2001,1,1]]},"DOI":"10.1080\/09546630152607899","type":"journal-article","created":{"date-parts":[[2002,9,20]],"date-time":"2002-09-20T19:20:05Z","timestamp":1032549605000},"page":"159-162","source":"Crossref","is-referenced-by-count":45,"title":["Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis"],"prefix":"10.1080","volume":"12","author":[{"given":"R","family":"Salmanpour, F Handjani, M K Nouhpisheh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"Berman JD, Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Inject Dis (1997) 24:684-703.","DOI":"10.1093\/clind\/24.4.684"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Dowlati Y, Cutaneous leishmaniasis: clinical aspect. Clin Dermatol (1996) 14:425-31.","DOI":"10.1016\/0738-081X(96)00058-2"},{"key":"CIT0003","unstructured":"World Health Organization. Control of leishmaniasis. Report of a WHO Expert Committee. Technical Report Series. 743. Geneva: WHO. 1990."},{"key":"CIT0004","doi-asserted-by":"crossref","unstructured":"Grog] M Thomason TN, Kranke KD. Drug resistance in leishmaniasis: its implications in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med (1992)47:117-26.","DOI":"10.4269\/ajtmh.1992.47.117"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Berman JD, Goad LJ. Beach DH. HoIz GG Jr. Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells. Mol Biochem Parasitai (1986) 20: 85-92.","DOI":"10.1016\/0166-6851(86)90145-3"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Urcayo E, Zaias N, Oral ketoconazole in the treatment of leishmaniasis.Int J Dermatol (1982)21:414-16.","DOI":"10.1111\/j.1365-4362.1982.tb03163.x"},{"key":"CIT0007","doi-asserted-by":"crossref","unstructured":"Jolliffe DS, Cutaneous leishmaniasis in Belize-treatment with ketoconazole. CIin Exp Dermatol (1986) 11:62-8.","DOI":"10.1111\/j.1365-2230.1986.tb00425.x"},{"key":"CIT0008","doi-asserted-by":"crossref","unstructured":"Alsaleh QA, Dvorak R, Manda A, Ketoconazole in the treatment of cutaneous leishmaniasis in Kuwait. Int J Dermatol (1995) 14:495-7.","DOI":"10.1111\/j.1365-4362.1995.tb00622.x"},{"key":"CIT0009","doi-asserted-by":"crossref","unstructured":"Saenz RE, Paz H, Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasiis. Am J Med (1990) 89:147-55","DOI":"10.1016\/0002-9343(90)90292-L"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Navin TR, Arana BA, Arana FE, et al, Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.J Infect Dis (1992) 165: 528-34.","DOI":"10.1093\/infdis\/165.3.528"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Ozgoztasi O, Baydar I, A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. Int J Dermatol (1997) 36: 61-3.","DOI":"10.1046\/j.1365-4362.1997.00022.x"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Ardehali S, Moattari A, Hosseini SMH, Sharifl I, Characterization of Leishmania isolated in Iran: 1. Serotyping with species specific monoclonal antibodies. Acta Tropica (2000) 75: 301-7.","DOI":"10.1016\/S0001-706X(00)00064-4"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546630152607899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T19:04:02Z","timestamp":1661195042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546630152607899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,1,1]]}},"alternative-id":["10.1080\/09546630152607899"],"URL":"https:\/\/doi.org\/10.1080\/09546630152607899","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1,1]]}}}